https://biotechmorning.com/news/wave-life-sciences-single-trial-rna-editing-aatd Biotech Morning en 2026-10-02T14:15:39.514Z One Trial to Rule Them All: Wave's Audacious Bet on RNA Editing https://biotechmorning.com/news/regeneron-muscle-mass-wegovy-trevogrumab Biotech Morning en 2026-10-02T14:14:53.759Z Regeneron Found a Way to Give Back the Muscle Wegovy Took https://biotechmorning.com/news/foghorn-lilly-breakup-layoffs Biotech Morning en 2026-10-02T14:14:04.978Z A Mega-Deal Breakup Just Gutted This Biotech's Future https://biotechmorning.com/news/novartis-abogen-mrna-t-cell-engager-deal Biotech Morning en 2026-10-02T14:13:20.562Z Novartis Just Bet $7.8 Billion That Your Body Can Build Its Own Drug Factory https://biotechmorning.com/news/adecto-biotech-shutdown-funding-crisis Biotech Morning en 2026-10-02T14:12:26.856Z The Biotech That Did Everything Right and Still Couldn't Survive https://biotechmorning.com/news/daiichi-astrazeneca-summit-adc-bispecific-combo-trial Biotech Morning en 2026-10-02T14:11:42.354Z Three Pharma Giants Walk Into a Cancer Trial https://biotechmorning.com/news/fresenius-kabi-mabxience-full-acquisition Biotech Morning en 2026-10-02T14:10:54.981Z Why Fresenius Kabi Just Spent €750 Million on a Company It Already Owned https://biotechmorning.com/news/camzyos-first-pediatric-ohcm-approval Biotech Morning en 2026-10-02T14:10:14.712Z The Heart Drug That Just Rewrote the Rules for Sick Teenagers https://biotechmorning.com/news/amgen-horizon-sjogrens-phase-3-win Biotech Morning en 2026-10-02T14:09:28.052Z Amgen's $28 Billion Bet on Horizon Just Got a Whole Lot Smarter https://biotechmorning.com/news/novartis-alteogen-3-2-billion-drug-delivery-deal Biotech Morning en 2026-10-02T14:08:44.085Z Novartis Just Spent $3.2 Billion on a Technology You've Never Heard Of https://biotechmorning.com/news/varda-251-million-space-drug-manufacturing Biotech Morning en 2026-10-01T14:17:56.377Z The $251 Million Bet on Making Drugs Where There's No Gravity https://biotechmorning.com/news/sanofi-regeneron-billion-dollar-early-stage-deal Biotech Morning en 2026-10-01T14:17:10.806Z Sanofi Just Wrote Regeneron a $1 Billion Check for Drugs That Barely Exist https://biotechmorning.com/news/bms-admilparant-liver-safety-death-fibrosis Biotech Morning en 2026-10-01T14:16:25.694Z The Fibrosis Drug That Killed a Patient Nobody Can Identify https://biotechmorning.com/news/tarlatamab-durvalumab-first-line-sclc-survival Biotech Morning en 2026-10-01T14:15:42.919Z The Cancer Drug Combo That Just Made Immunotherapy History https://biotechmorning.com/news/lilly-amylin-zepbound-combo-record-weight-loss Biotech Morning en 2026-10-01T14:14:53.230Z Lilly's New Weight-Loss Combo Just Smashed Every Record on the Scale https://biotechmorning.com/news/merck-tl1a-hidradenitis-suppurativa-phase-2-win Biotech Morning en 2026-10-01T14:14:05.350Z Merck's $10.8 Billion Bet Just Paid Off in a Place Nobody Expected https://biotechmorning.com/news/viking-obesity-drug-monthly-dosing Biotech Morning en 2026-10-01T14:13:22.423Z The Obesity Shot That Wants You to Forget About It https://biotechmorning.com/news/giredestrant-oral-serd-breast-cancer-evera Biotech Morning en 2026-10-01T14:12:40.350Z The Pill That Could Replace the Needle in Breast Cancer Treatment https://biotechmorning.com/news/fenebrutinib-ms-pill-fda-priority-review Biotech Morning en 2026-10-01T14:11:54.514Z The MS Pill That Wants to Replace Your Infusion https://biotechmorning.com/news/hhs-ai-clinical-trial-overhaul Biotech Morning en 2026-10-01T14:11:08.159Z The Government Wants to Blow Up How Clinical Trials Work